We have agreed to reimburse the underwriters for certain fees and expenses of counsel to the underwriters related to FINRA and blue sky matters, in an amount not to exceed $100,000.
Option to purchase additional ordinary shares
The underwriters have an option, exercisable for 30 days after the date of this prospectus, to purchase up to 1,009,587 additional ordinary shares from the selling shareholders at the public offering price, less the underwriting discount. If the underwriters exercise this option, each will be obligated, subject to conditions contained in the underwriting agreement, to purchase a number of additional ordinary shares proportionate to that underwriter’s initial amount reflected in the above table.
No sales of similar securities
We, the selling shareholders and certain other holders of our shares outstanding immediately prior to this offering have agreed not to sell or transfer any of our ordinary shares or securities convertible into, exchangeable for, exercisable for, or repayable with our ordinary shares, for 90 days after the date of this prospectus without first obtaining the prior written consent of the representatives. Specifically, we and these other persons have agreed, with certain limited exceptions, not to directly or indirectly:
•
offer, pledge, sell or contract to sell any of our ordinary shares;
•
sell any option or contract to purchase any of our ordinary shares;
•
purchase any option or contract to sell any of our ordinary shares;
•
grant any option, right or warrant for the sale of any of our ordinary shares;
•
lend or otherwise dispose of or transfer any of our ordinary shares;
•
request or demand that we file a registration statement related to our ordinary shares; or
•
enter into any swap or other agreement that transfers, in whole or in part, the economic consequence of ownership of any of our ordinary shares whether any such swap or transaction is to be settled by delivery of our ordinary shares or other securities, in cash or otherwise.
In the case of the Company, the restrictions described in the immediately preceding paragraph do not apply to certain transactions including:
•
transfers pursuant to share option plans or other employee compensation plans existing on the date of the underwriting agreement and described in this prospectus; and
•
the issuance of an aggregate number of ordinary shares pursuant to agreements relating to and in connection with bona fide commercial relationships not to exceed ten percent (10%) of the total number of ordinary shares outstanding on the date of this prospectus.
In the case of the selling shareholders and certain other holders of our ordinary shares outstanding immediately prior to this offering, the restrictions described in the paragraph above do not apply to certain transactions including:
•
the sale of ordinary shares to the underwriters pursuant to the underwriting agreement in this offering;
•
transfers of ordinary shares acquired in the open market after the completion of this offering;
•
subject to certain limitations, a bona fide gift;
•
subject to certain limitations, transfers by will or upon intestate succession or transfers that occur by operation of law;
•
subject to certain limitations, transfers to any trusts for the direct or indirect benefit of the transferor or the transferor’s immediate family;